BusinessVisionGate’s Cell-CT™ 3D Cellular Imaging Platform Detects the Presence of Cancer-Associated Cells (CACs) that have undergone Malignancy Associated Change (MAC)By Nasdaq OMXApr 16, 2018, 1:23 PM UTC
